At close: December 20 at 4:00:01 PM EST
After hours: December 20 at 4:15:01 PM EST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 3 | 1 | 3 | 3 |
| Avg. Estimate | -0.17 | -0.16 | -0.41 | -0.68 |
| Low Estimate | -0.19 | -0.16 | -0.43 | -0.72 |
| High Estimate | -0.15 | -0.16 | -0.39 | -0.63 |
| Year Ago EPS | -0.22 | -0.17 | -0.74 | -0.41 |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 6 | 2 | 8 | 6 |
| Avg. Estimate | 187.5k | 100k | 658.12k | 4.62M |
| Low Estimate | -- | -- | 490k | -- |
| High Estimate | 700k | 200k | 1.2M | 26.6M |
| Year Ago Sales | 141.56k | 148k | 391.7k | 658.12k |
| Sales Growth (year/est) | 32.45% | -32.43% | 68.02% | 601.62% |
Earnings History
| Currency in USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | 0.25 | -0.23 | -0.24 | -0.23 |
| EPS Actual | -0.22 | -0.17 | 0.12 | -0.2 |
| Difference | -0.47 | 0.06 | 0.36 | 0.03 |
| Surprise % | -187.32% | 26.64% | 150.12% | 11.89% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.17 | -0.16 | -0.41 | -0.68 |
| 7 Days Ago | -0.17 | -0.17 | -0.41 | -0.69 |
| 30 Days Ago | -0.2 | -0.16 | -0.48 | -0.72 |
| 60 Days Ago | -0.2 | -0.16 | -0.48 | -0.72 |
| 90 Days Ago | -0.2 | -0.24 | -0.48 | -0.72 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | -- | -- | 1 |
| Up Last 30 Days | 2 | -- | 2 | 2 |
| Down Last 7 Days | -- | 1 | -- | -- |
| Down Last 30 Days | 1 | 1 | 1 | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| OVID | 22.98% | 5.88% | 44.54% | -65.90% |
| S&P 500 | 5.00% | 12.00% | 2.10% | 12.20% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 12/4/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 9/30/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 8/19/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 7/26/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 7/2/2024 |
| Maintains | BTIG: Buy to Buy | 6/18/2024 |
Related Tickers
LXEO Lexeo Therapeutics, Inc.
6.28
+3.97%
SKYE Skye Bioscience, Inc.
2.7000
-5.59%
RYTM Rhythm Pharmaceuticals, Inc.
56.12
+1.15%
SPRB Spruce Biosciences, Inc.
0.4000
+4.68%
PRAX Praxis Precision Medicines, Inc.
76.52
+5.05%
CMPX Compass Therapeutics, Inc.
1.3800
+0.73%
STOK Stoke Therapeutics, Inc.
11.68
+3.36%
SLNO Soleno Therapeutics, Inc.
45.18
-0.04%
CRGX CARGO Therapeutics, Inc.
14.90
+10.29%
GLPG Galapagos NV
26.76
+1.48%